Nano-X Imaging (NASDAQ:NNOX - Free Report) had its price objective upped by Cantor Fitzgerald from $11.00 to $12.00 in a research note released on Friday,Benzinga reports. The brokerage currently has an overweight rating on the stock.
Nano-X Imaging Price Performance
Shares of NASDAQ NNOX traded up $1.73 during midday trading on Friday, hitting $7.97. The stock had a trading volume of 16,959,342 shares, compared to its average volume of 1,585,114. Nano-X Imaging has a fifty-two week low of $5.26 and a fifty-two week high of $14.28. The company's 50-day simple moving average is $6.11 and its 200 day simple moving average is $6.89. The firm has a market cap of $460.51 million, a P/E ratio of -9.38 and a beta of 2.02.
Hedge Funds Weigh In On Nano-X Imaging
Large investors have recently modified their holdings of the company. Griffin Asset Management Inc. increased its holdings in Nano-X Imaging by 0.7% during the 2nd quarter. Griffin Asset Management Inc. now owns 203,911 shares of the company's stock worth $1,497,000 after purchasing an additional 1,500 shares in the last quarter. Price T Rowe Associates Inc. MD grew its holdings in Nano-X Imaging by 13.3% during the first quarter. Price T Rowe Associates Inc. MD now owns 13,716 shares of the company's stock worth $135,000 after buying an additional 1,612 shares in the last quarter. The Manufacturers Life Insurance Company raised its position in Nano-X Imaging by 14.8% in the 2nd quarter. The Manufacturers Life Insurance Company now owns 20,210 shares of the company's stock valued at $148,000 after buying an additional 2,600 shares during the last quarter. Van ECK Associates Corp boosted its holdings in Nano-X Imaging by 14.1% during the 2nd quarter. Van ECK Associates Corp now owns 22,293 shares of the company's stock worth $164,000 after acquiring an additional 2,755 shares during the last quarter. Finally, Rhumbline Advisers grew its stake in shares of Nano-X Imaging by 3.9% in the 2nd quarter. Rhumbline Advisers now owns 75,920 shares of the company's stock worth $557,000 after acquiring an additional 2,818 shares in the last quarter. 21.49% of the stock is currently owned by institutional investors.
About Nano-X Imaging
(
Get Free Report)
Nano-X Imaging Ltd. develops a commercial-grade tomographic imaging device with a digital X-ray source. The company provides teleradiology services and develops artificial intelligence applications to be used in real-world medical imaging applications. Its X-ray source is based on a digital micro-electro-mechanical systems semiconductor cathode.
Featured Stories
Before you consider Nano-X Imaging, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Nano-X Imaging wasn't on the list.
While Nano-X Imaging currently has a "Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Need to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
